We investigated the impact of obesity on uterine contractions during late pregnancy and identified FABP4‐mediated cholesterol metabolism as a key pathway in vivo and in vitro levels. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.